“I became a physician to help patients. I became an entrepreneur to help millions more.”- Dr. Ashwani Dhar
Why I Started This Journey
As a practicing physician, I saw firsthand the gaps in our healthcare system. Patients struggled to access quality medications at affordable prices. Clinical trials were slow and inefficient. The disconnect between clinical care and healthcare innovation was striking.
My time at Cerner/Oracle Health as Chief Medical Informatics Officer taught me how technology could transform healthcare delivery. But I wanted to do more than advise from the sidelines. I wanted to build solutions that would directly impact patient lives.
That's why I founded ThinkRoman Ventures- to create a platform where my clinical experience could fuel healthcare innovation. It wasn't about starting one company; it was about building an ecosystem where multiple healthcare solutions could flourish.
The Birth of Kairos R&D Solutions
Clinical research is the backbone of medical progress, yet the process was plagued by inefficiencies. Patient recruitment took forever. Documentation was a nightmare. Smaller sponsors struggled to compete.
Kairos R&D Solutions was my answer. We built a Clinical Research Organization that leverages AI for patient matching, streamlined document management through Kairodox, and made research accessible to sponsors of all sizes.
The name “Kairos” comes from the Greek word for the opportune moment - the perfect time to act. In clinical research, timing is everything. We help our partners seize that moment.
Creating TrPharma and KashMOX 625
In my years of practice, I prescribed antibiotics countless times. I knew which ones worked best and which ones patients struggled to afford. The gap between quality and accessibility troubled me.
TrPharma was born from this frustration. I wanted to create a pharmaceutical division that combined clinical knowledge with manufacturing excellence - medicines developed by someone who actually prescribed them.
KashMOX 625 became our flagship product - a WHO-GMP certified Amoxicillin-Clavulanate antibiotic that offers the same efficacy as premium brands at an accessible price. When I developed its formulation, I drew on years of clinical experience to ensure it met the highest standards.
We followed with One87 Plus (880 PLUS) for pain management and KashCAL PLUS for bone health - each developed with the same physician-first approach.
My Philosophy: Doctor-Led Innovation
I believe healthcare innovation should be led by people who understand patient care at its core. Not just from business cases or market research, but from years of sitting with patients, understanding their fears, and witnessing their recoveries.
Every decision at ThinkRoman Ventures - whether it's a clinical trial protocol at Kairos or a drug formulation at TrPharma - is filtered through a simple question: “Would I prescribe this to my own family?”
This isn't just business philosophy; it's a commitment to the patients who trust us with their health.
“The future of healthcare isn't just about new technologies - it's about new approaches that put patients first. That's what drives everything I build.”- Dr. Ashwani Dhar, MD, DMI
Founder & CEO, ThinkRoman Ventures | Kairos R&D Solutions | TrPharma